Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.

Oldenburg J, Hay CRM, Jiménez-Yuste V, Peyvandi F, Schved JF, Szamosi J, Winding B, Lethagen S.

BMJ Open. 2019 May 30;9(5):e028012. doi: 10.1136/bmjopen-2018-028012.

2.

Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B.

Shapiro AD, Pasi KJ, Ozelo MC, Kulkarni R, Barnowski C, Winding B, Szamosi J, Lethagen S.

Res Pract Thromb Haemost. 2018 Nov 29;3(1):109-113. doi: 10.1002/rth2.12163. eCollection 2019 Jan.

3.

Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.

Oldenburg J, Kulkarni R, Srivastava A, Mahlangu JN, Blanchette VS, Tsao E, Winding B, Dumont J, Jain N.

Haemophilia. 2018 Jan;24(1):77-84. doi: 10.1111/hae.13353. Epub 2017 Oct 30.

PMID:
29082639
4.

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: a necessary precaution when testing novel anti-resorptive therapies.

Amhlaoibh RN, Hoegh-Andersen P, Brünner N, Sørensen A, Winding B, Holst-Hansen C, Karsdal MA, Engsig MT, Delaissé JM, Heegaard AM.

Clin Exp Metastasis. 2004;21(1):65-74.

PMID:
15065604
5.

Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.

Winding B, Misander H, Høegh-Andersen P, Brünner N, Foged NT.

Breast Cancer Res Treat. 2003 Mar;78(2):205-16.

PMID:
12725420
6.

Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.

Winding B, NicAmhlaoibh R, Misander H, Høegh-Andersen P, Andersen TL, Holst-Hansen C, Heegaard AM, Foged NT, Brünner N, Delaissé JM.

Clin Cancer Res. 2002 Jun;8(6):1932-9.

8.

Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis.

Winding B, Misander H, Sveigaard C, Therkildsen B, Jakobsen M, Overgaard T, Oursler MJ, Foged NT.

J Cancer Res Clin Oncol. 2000 Nov;126(11):631-40.

PMID:
11079727
9.

Proteinases in bone resorption: obvious and less obvious roles.

Delaissé JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard AM, Neff L, Baron R, Foged NT.

Clin Chim Acta. 2000 Feb 15;291(2):223-34. Review.

PMID:
10675725
10.

Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.

Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ.

Cancer Res. 1999 Nov 15;59(22):5849-55.

12.

Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness.

Pederson L, Kremer M, Foged NT, Winding B, Ritchie C, Fitzpatrick LA, Oursler MJ.

J Bone Miner Res. 1997 May;12(5):742-52.

13.

Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay.

Foged NT, Delaissé JM, Hou P, Lou H, Sato T, Winding B, Bonde M.

J Bone Miner Res. 1996 Feb;11(2):226-37.

PMID:
8822347
14.

Desensitization and reactivation of ACh-regulated exocrine secretion in hen tracheal epithelium.

Winding B, Bindslev N.

Am J Physiol. 1993 Feb;264(2 Pt 1):C342-51.

PMID:
8447367
15.

Second messengers and ion channels in acetylcholine-induced chloride secretion in hen trachea.

Winding B, Winding H, Bindslev N.

Comp Biochem Physiol C. 1992 Sep;103(1):195-205.

PMID:
1280547
16.

Characterization of a muscarinic receptor controlling Cl- secretion in hen trachea.

Winding B, Bindslev N.

Am J Physiol. 1990 Jun;258(6 Pt 1):C982-7.

PMID:
1694400

Supplemental Content

Loading ...
Support Center